The Boston NETT Group

描述（由申请人提供）：我们建议创建波士顿NETT网站，这是一个由波士顿的医院和EMS机构组成的团队，它将作为一个最热门的注册网站和对NETT网络充满活力的贡献者。我们的小组包括波士顿市所有的成人一级创伤中心。所有医院都有成功管理和临床试验表现的良好记录。特别是，所有医院都有既定的研究基础设施，在急诊科和神经科进行持续的临床研究，可以利用这些基础设施来满足NETT的需求。首席研究员Joshua N. Goldstein（医学博士）和联合研究员Jonathan Rosand（医学博士）在管理成功的临床研究项目、指导委员会成员和各自领域的国家领导职位方面具有互补的技能。我们的团队包括神经病学和急诊医学方面的研究人员，他们具有全国公认的专业知识，可以管理在急诊环境中登记患者的艰巨任务。波士顿奈特集团的优势包括：1)多个研究人员之间密切的个人和专业联系，如成功的合作研究项目的历史所示；2)来自主要大都市地区的大量人口跨越了各种神经系统疾病；3)具有科研成果和创新记录的优秀现场调查员团队，以及多中心试验的受试者招募和数据管理；4)现有的研究基础设施，由包括NINDS在内的一系列来源资助，可以用来满足NETT的需要；5)众多现有的临床研究项目，包括神经病学临床试验单元、哈佛催化剂临床和转化科学奖（CTSA）项目、波士顿大学临床和转化科学（CTSA）研究所、急性卒中转化研究专业项目（SPOTRIAS）网络、NeuroNEXT网络和NeuroNEXT临床协调中心；6)与院前服务紧密结合，包括Boston EMS和Boston Medflight。总的来说，波士顿奈特集团拥有资源、愿景和热情来促进奈特网络的持续成功。

DESCRIPTION (provided by applicant): We propose to create the Boston NETT Site, a team of hospitals and EMS agencies in Boston that will serve as a top-enrolling site and vibrant contributor to the NETT Network. Our group includes all adult Level I trauma centers in the city of Boston. All hospitals have a proven track record of successful management and performance of clinical trials. In particular, all hospitals have an established research infrastructure that performs ongoing clinical research in both emergency and neurology departments, which can be leveraged to meet the needs of NETT. Principal investigator Joshua N. Goldstein, MD, PhD, and Co-investigator Jonathan Rosand, MD, MS bring a complementary set of skills in managing successful clinical research programs, membership on Steering Committees, and positions of national leadership in their fields. Our team includes investigators in neurology and emergency medicine with nationally recognized expertise managing the difficult task of enrolling patients in the emergency setting. Strengths of the Boston NETT Group include 1) the close personal and professional ties between multiple investigators, as shown by a history of successful collaborative research projects; 2) a large population from a major metropolitan area that spans the full range of neurologic disorders; 3) talented teams of site Investigators with track records of scientific achievement and innovation, as well as subject recruitment and data management in multicenter trials; 4) an existing research infrastructure, funded by a range of sources including NINDS, which can be leveraged to meet the needs of NETT; 5) numerous existing clinical research programs including the Neurology Clinical Trials Unit, The Harvard Catalyst Clinical and Translational Science Award (CTSA) program, the BU Clinical and Translational Science (CTSA) Institute, the Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS) Network, the NeuroNEXT Network, and the NeuroNEXT Clinical Coordinating Center; 6) close integration with pre-hospital services, including Boston EMS and Boston Medflight. Overall, the Boston NETT Group has the resources, vision, and enthusiasm to enhance the ongoing success of the NETT Network.